Supporting Treatment Adherence for Resilience and Thriving (START)

Completed · Not applicable

Conditions studied: Adherence, Medication, HIV-1-infection, Stimulant Use

In brief

This Phase II randomized controlled trial is testing the efficacy of a cell phone application called START for helping men who use stimulants like methamphetamine to get the most out of their HIV treatment.

Key facts

Study ID

NCT05140876

Run by

Florida International University

People needed

286

Starts

2022-06-15

Expected to finish

2025-07-31

Last updated by the study team

2026-02-17

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may not qualify if…

• HIV-negative or never tested for HIV;
• HIV-positive men without a current ART prescription;
• Does not return a viable DBS specimen at baseline for viral load testing
• Not a sexual minority man

Where it is running

• Florida International University — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.